Journal of Pharmaceutical Analysis (Jul 2023)

Cux1+ proliferative basal cells promote epidermal hyperplasia in chronic dry skin disease identified by single-cell RNA transcriptomics

  • Minhua Huang,
  • Ning Hua,
  • Siyi Zhuang,
  • Qiuyuan Fang,
  • Jiangming Shang,
  • Zhen Wang,
  • Xiaohua Tao,
  • Jianguo Niu,
  • Xiangyao Li,
  • Peilin Yu,
  • Wei Yang

Journal volume & issue
Vol. 13, no. 7
pp. 745 – 759

Abstract

Read online

Pathological dry skin is a disturbing and intractable healthcare burden, characterized by epithelial hyperplasia and severe itch. Atopic dermatitis (AD) and psoriasis models with complications of dry skin have been studied using single-cell RNA sequencing (scRNA-seq). However, scRNA-seq analysis of the dry skin mouse model (acetone/ether/water (AEW)-treated model) is still lacking. Here, we used scRNA-seq and in situ hybridization to identify a novel proliferative basal cell (PBC) state that exclusively expresses transcription factor CUT-like homeobox 1 (Cux1). Further in vitro study demonstrated that Cux1 is vital for keratinocyte proliferation by regulating a series of cyclin-dependent kinases (CDKs) and cyclins. Clinically, Cux1+ PBCs were increased in patients with psoriasis, suggesting that Cux1+ PBCs play an important part in epidermal hyperplasia. This study presents a systematic knowledge of the transcriptomic changes in a chronic dry skin mouse model, as well as a potential therapeutic target against dry skin-related dermatoses.

Keywords